Tag: SGLT2 inhibitors
-
New Horizons in Heart Failure Treatment: Clinician Education
Introduction: A new ACC program to elevate heart failure care The American College of Cardiology (ACC) is launching Transformation of HF Care: New Horizons in Treatment, an 18-month education program designed to equip clinicians with the latest advances in heart failure (HF) management. The initiative seeks to bridge gaps between evolving research and everyday practice,…
-
New ACC Program Aims to Educate Clinicians on the Latest Advances in Heart Failure Treatment
Overview: Transforming Heart Failure Care Heart failure (HF) remains a leading cause of hospitalization and a significant public health challenge, with more than 6 million Americans affected. The American College of Cardiology (ACC) has launched a new educational initiative, Transformation of HF Care: New Horizons in Treatment, designed to equip clinicians with the latest advances…
-
Transformation of Heart Failure Care: New Horizons in Treatment for Clinicians
Introduction: A New Educational Era in Heart Failure Care The American College of Cardiology (ACC) is launching Transformation of HF Care: New Horizons in Treatment, an 18-month program designed to equip clinicians with the latest advances in heart failure (HF) management. As the disease remains a leading cause of hospitalization and increasingly affects diverse populations,…